Insider Trading: Actavis Inc (ACT)

ACT on New York Consolidated

130.20USD
21 May 2013
Price Change (% chg)

$3.05 (+2.40%)
Prev Close
$125.50
Open
$127.02
Day's High
$131.14
Day's Low
$125.49
Volume
2,762,851
Avg. Vol
1,546,854
52-wk High
$131.24
52-wk Low
$67.67

Search Stocks
MAYR CHARLES M
Trading Date Type Shares Traded Price Shares Held
13 Mar 2013 Sell 1,000 $91.77 28,310
5 Mar 2013 Buy 3,070 $0.00 29,310
5 Mar 2013 Buy 4,421 $0.00 29,310
1 Mar 2013 Sell 1,880 $85.54 21,819
30 Oct 2012 Buy 2,909 $0.00 23,699
7 Mar 2012 Buy 4,276 $0.00 20,790
7 Mar 2012 Buy 5,199 $0.00 20,790
23 Feb 2012 Sell 478 $58.17 11,315
20 Sep 2011 Sell 632 $70.04 11,793
Previous Page 1 of 1

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 625
Total Shares Held: 153,200,245
3 Mo. Net Change: 6,439,270
# New Positions: 61
# Closed Positions: 82
# Increased Positions: 263
# Reduced Positions: 315
# Net Buyers: -52

Officers & Directors

Name Age Since Current Position

Andrew Turner

 66 2008 Independent Chairman of the Board

Paul Bisaro

 52 2007 President, Chief Executive Officer, Director

Sigurdur Olafsson

 44 2012 President - Actavis Pharma

Robert Stewart

 45 2012 President - Global Operations

G. Frederick Wilkinson

 56 2012 President - Actavis Specialty Brands

David Buchen

 48 2012 Chief Legal Officer, Global

Patrick Eagan

 55 2012 Chief Human Resource Officer, Global

R. Todd Joyce

 55 2012 Chief Financial Officer, Global

Charles Mayr

 56 2012 Chief Communication Officer, Global

Christopher Bodine

 57 2009 Independent Director

Michael Fedida

 66 1995 Independent Director

Michel Feldman

 70 2002 Independent Director

Albert Hummel

 68 1991 Independent Director

Catherine Klema

 54 2004 Independent Director

Jack Michelson

 78 2002 Independent Director

Ronald Taylor

 65 1994 Independent Director

Fred Weiss

 71 2000 Independent Director

Lisa DeFrancesco

 VP, Global Investor Relations
Search Stocks